JP2003501396A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2003501396A5 JP2003501396A5 JP2001501241A JP2001501241A JP2003501396A5 JP 2003501396 A5 JP2003501396 A5 JP 2003501396A5 JP 2001501241 A JP2001501241 A JP 2001501241A JP 2001501241 A JP2001501241 A JP 2001501241A JP 2003501396 A5 JP2003501396 A5 JP 2003501396A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- interleukin
- effective amount
- therapeutically effective
- mammal
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US13805499P | 1999-06-08 | 1999-06-08 | |
| US60/138,054 | 1999-06-08 | ||
| PCT/US2000/015737 WO2000074707A2 (en) | 1999-06-08 | 2000-06-08 | Use of interleukin-11 to treat hemorrhagic shock |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2003501396A JP2003501396A (ja) | 2003-01-14 |
| JP2003501396A5 true JP2003501396A5 (https=) | 2007-08-16 |
Family
ID=22480226
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2001501241A Pending JP2003501396A (ja) | 1999-06-08 | 2000-06-08 | 出血性ショックを処置するためのインターロイキン−１１の使用 |
Country Status (9)
| Country | Link |
|---|---|
| EP (1) | EP1185292B1 (https=) |
| JP (1) | JP2003501396A (https=) |
| CN (1) | CN1355707A (https=) |
| AT (1) | ATE294590T1 (https=) |
| AU (1) | AU5328800A (https=) |
| CA (1) | CA2376358A1 (https=) |
| DE (1) | DE60019921T2 (https=) |
| MX (1) | MXPA01012663A (https=) |
| WO (1) | WO2000074707A2 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6953777B2 (en) | 1999-03-11 | 2005-10-11 | Genetics Indtitute LLC | Use of interleukin-11 to prevent immune-mediated cytotoxicity |
| US6982080B2 (en) | 2002-03-15 | 2006-01-03 | Wyeth | Hydroxyethyl starch—containing polypeptide compositions |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5460810A (en) * | 1992-09-02 | 1995-10-24 | Genetics Institute, Inc. | Method for maintaining gut epithelial cells by treatment with a cytokine such as interleukin 11 |
-
2000
- 2000-06-08 AT AT00938215T patent/ATE294590T1/de not_active IP Right Cessation
- 2000-06-08 CA CA002376358A patent/CA2376358A1/en not_active Abandoned
- 2000-06-08 EP EP00938215A patent/EP1185292B1/en not_active Expired - Lifetime
- 2000-06-08 JP JP2001501241A patent/JP2003501396A/ja active Pending
- 2000-06-08 WO PCT/US2000/015737 patent/WO2000074707A2/en not_active Ceased
- 2000-06-08 CN CN00808737A patent/CN1355707A/zh active Pending
- 2000-06-08 AU AU53288/00A patent/AU5328800A/en not_active Abandoned
- 2000-06-08 MX MXPA01012663A patent/MXPA01012663A/es active IP Right Grant
- 2000-06-08 DE DE60019921T patent/DE60019921T2/de not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2002536387A5 (https=) | ||
| JP2003503454A5 (https=) | ||
| USD449357S1 (en) | Platform for gymnastics | |
| JP2002532112A5 (https=) | ||
| WO2004056337A3 (en) | Oral dosage forms with therapeutically active agents in controlled release cores and immediate release gelatin capsule coats | |
| JP2003516325A5 (https=) | ||
| JP2002509074A5 (https=) | ||
| JP2003501516A5 (https=) | ||
| JP2003520017A5 (https=) | ||
| IL130838A (en) | Formulation for inhalation having a poured bulk density of 0.28 to 0.38 g/ml, a process for preparing the formulation and the use thereof | |
| PL362982A1 (en) | Benzothiophene derivative compounds, process for the preparation and use thereof | |
| IL134079A0 (en) | Process for the preparation of pellets with a content of up to 90 wt % of a pharmaceutically active ingredient | |
| JP2003517041A5 (https=) | ||
| JP2003508328A5 (https=) | ||
| JP2004500325A5 (https=) | ||
| JP2002522501A5 (https=) | ||
| JP2001513504A5 (https=) | ||
| JP2003501396A5 (https=) | ||
| EE200300139A (et) | Kemokiini mutandi kasutamine farmatseutilise kompositsiooni valmistamiseks, mis on ette nähtud hulgiskleroosi ja teiste müeliinikaotusega seotud haiguste raviks | |
| JP2002537232A5 (https=) | ||
| JP2000352551A5 (https=) | ||
| JP2002114686A5 (https=) | ||
| JP2003512511A5 (https=) | ||
| JPH10237071A5 (https=) | ||
| JP2003516751A5 (https=) |